Published in CPT Pharmacometrics Syst Pharmacol on February 05, 2014
Entolimod, an Adjuvant for Vaccine Augmentation | NCT03063736
Exploring BSEP inhibition-mediated toxicity with a mechanistic model of drug-induced liver injury. Front Pharmacol (2014) 0.93
Hepatoprotective effect of Rhodiola imbricata rhizome against paracetamol-induced liver toxicity in rats. Saudi J Biol Sci (2014) 0.78
Impact of Propionic Acid on Liver Damage in Rats. Int J Mol Cell Med (2015) 0.75
Synergistic hepatoprotective potential of ethanolic extract of Solanum xanthocarpum and Juniperus communis against paracetamol and azithromycin induced liver injury in rats. J Tradit Complement Med (2015) 0.75
The transformation in biomarker detection and management of drug-induced liver injury. Liver Int (2017) 0.75
Refining Liver Safety Risk Assessment: Application of Mechanistic Modeling and Serum Biomarkers to Cimaglermin alfa (GGF2) Clinical Trials. Clin Pharmacol Ther (2017) 0.75
Intravenous N-acetylcystine: the treatment of choice for paracetamol poisoning. Br Med J (1979) 6.45
An agonist of toll-like receptor 5 has radioprotective activity in mouse and primate models. Science (2008) 4.89
Acetaminophen toxicity in an urban county hospital. N Engl J Med (1997) 4.26
Molecular forms of HMGB1 and keratin-18 as mechanistic biomarkers for mode of cell death and prognosis during clinical acetaminophen hepatotoxicity. J Hepatol (2012) 3.15
New drug and biological drug products; evidence needed to demonstrate effectiveness of new drugs when human efficacy studies are not ethical or feasible. Final rule. Fed Regist (2002) 3.07
Mathematical modeling of liver injury and dysfunction after acetaminophen overdose: early discrimination between survival and death. Hepatology (2012) 2.14
Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease. Hepatology (2008) 1.92
Successful living-related partial liver transplantation to an adult patient. Lancet (1994) 1.47
The temporal profile of increased transaminase levels in patients with acetaminophen-induced liver dysfunction. Ann Emerg Med (1995) 1.34
Histopathological changes in the liver following a paracetamol overdose: correlation with clinical and biochemical parameters. J Pathol (1975) 1.30
Aspartate aminotransferase activity and isoenzyme proportions in human liver tissues. Clin Chem (1978) 1.27
The Type 1 Diabetes PhysioLab Platform: a validated physiologically based mathematical model of pathogenesis in the non-obese diabetic mouse. Clin Exp Immunol (2010) 1.14
Liver regeneration in donors and adult recipients after living donor liver transplantation. Liver Transpl (2008) 1.13
Isoforms of alanine aminotransferases in human tissues and serum--differential tissue expression using novel antibodies. Arch Biochem Biophys (2007) 1.10
The effects of heparins on the liver: application of mechanistic serum biomarkers in a randomized study in healthy volunteers. Clin Pharmacol Ther (2012) 1.06
Aflatoxin B1-induced lipid peroxidation in rat liver. Toxicol Appl Pharmacol (1994) 1.02
In vitro to in vivo extrapolation and species response comparisons for drug-induced liver injury (DILI) using DILIsym™: a mechanistic, mathematical model of DILI. J Pharmacokinet Pharmacodyn (2012) 1.02
Live donor liver transplantation. Liver Transpl (2006) 0.99
The mechanisms relating to increases in plasma enzymes and isoenzymes in diseases of animals. Vet Clin Pathol (1983) 0.98
An analysis of N-acetylcysteine treatment for acetaminophen overdose using a systems model of drug-induced liver injury. J Pharmacol Exp Ther (2012) 0.98
Convergence process of volumetric liver regeneration after living-donor hepatectomy. J Gastrointest Surg (2011) 0.84
Modeling drug- and chemical-induced hepatotoxicity with systems biology approaches. Front Physiol (2012) 0.84
Hyper-transaminasemia with heparin therapy. Br Med J (1975) 0.79
Serum level of ornithine carbamoyltransferase is influenced by the state of Kupffer cells. Clin Chim Acta (2007) 0.78